Skip to content

Carpal Tunnel Syndrome and Amyloidosis

Carpal Tunnel Syndrome and Amyloidosis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04245098
Acronym
AMICAR
Enrollment
100
Registered
2020-01-28
Start date
2020-01-08
Completion date
2023-01-08
Last updated
2020-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyloidosis, Carpal Tunnel Syndrome

Keywords

carpal tunnel syndrome, amyloidosis

Brief summary

Carpal tunnel syndrome has been suggested to be an early sign of amyloidosi. The investigators will evaluate tissue samples obtained from patients undergoing carpal tunnel release surgery for amyloid.

Detailed description

Carpal tunnel syndrome (CTS) can be caused by the deposition and accumulation of misfolded proteins called amyloid and is often an early manifestation of systemic amyloidosis. Patients with cardiac amyloidosis often have carpal tunnel syndrome that precedes cardiac manifestations by several years, and many patients will have undergone surgery for idiopathic carpal tunnel syndrome since the protein also deposits in the transversal carpal ligament of the hand. The investigators sought to identify the prevalence and type of amyloid deposits in patients undergoing carpal tunnel surgery and evaluate for cardiac involvement

Interventions

PROCEDURECarpal tunnel syndrome surgery

Biopsy

Sponsors

Corporacion Parc Tauli
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients undergoing carpal tunnel syndrome surgery

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with amyloid deposits in patients undergoing carpal tunnel surgery2 yearsPrevalence of amyloid deposits in biopsy in patients undergoing carpal tunnel syndrome surgery

Secondary

MeasureTime frameDescription
Number of participants with cardiac involvement in echocardiogram2 yearsCardiac involment in echocardiography

Countries

Spain

Contacts

Primary ContactMaria del Carmen Navarro-Saez, M.D.
mnavarros@tauli.cat937 231 010

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026